These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
820 related items for PubMed ID: 29126913
21. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. Kim JY, Lee HY, Park KK, Choi YK, Nam JS, Hong IS. Oncotarget; 2016 Apr 12; 7(15):20395-409. PubMed ID: 26967248 [Abstract] [Full Text] [Related]
22. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas. Huang WC, Kuo KT, Adebayo BO, Wang CH, Chen YJ, Jin K, Tsai TH, Yeh CT. J Nutr Biochem; 2018 Apr 12; 54():140-150. PubMed ID: 29414668 [Abstract] [Full Text] [Related]
23. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway. Liu W, Zhao Z, Wang Y, Li W, Su Q, Jia Q, Zhang J, Zhang X, Shen J, Yin J. Cell Death Dis; 2018 Mar 01; 9(3):343. PubMed ID: 29497056 [Abstract] [Full Text] [Related]
24. E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling. McGonigle S, Chen Z, Wu J, Chang P, Kolber-Simonds D, Ackermann K, Twine NC, Shie JL, Miu JT, Huang KC, Moniz GA, Nomoto K. Oncotarget; 2015 Dec 01; 6(38):41307-23. PubMed ID: 26513298 [Abstract] [Full Text] [Related]
25. Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening. Li B, Liang J, Lu F, Zeng G, Zhang J, Ma Y, Liu P, Wang Q, Zhou Q, Chen L. Molecules; 2020 Apr 06; 25(7):. PubMed ID: 32268564 [Abstract] [Full Text] [Related]
27. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway. Ma Y, Zhu B, Liu X, Yu H, Yong L, Liu X, Shao J, Liu Z. J Exp Clin Cancer Res; 2015 Oct 06; 34():115. PubMed ID: 26444270 [Abstract] [Full Text] [Related]
34. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells. Zhu J, Jiang Y, Yang X, Wang S, Xie C, Li X, Li Y, Chen Y, Wang X, Meng Y, Zhu M, Wu R, Huang C, Ma X, Geng S, Wu J, Zhong C. Biochem Biophys Res Commun; 2017 Jan 01; 482(1):15-21. PubMed ID: 27836540 [Abstract] [Full Text] [Related]
36. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells. Li X, Wang X, Xie C, Zhu J, Meng Y, Chen Y, Li Y, Jiang Y, Yang X, Wang S, Chen J, Zhang Q, Geng S, Wu J, Zhong C, Zhao Y. Anticancer Drugs; 2018 Mar 01; 29(3):208-215. PubMed ID: 29356693 [Abstract] [Full Text] [Related]
37. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy. Cui Y, Zhao M, Yang Y, Xu R, Tong L, Liang J, Zhang X, Sun Y, Fan Y. Acta Biomater; 2022 Oct 15; 152():380-392. PubMed ID: 36028199 [Abstract] [Full Text] [Related]
38. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition. Wang W, Chen D, Zhu K. J Exp Clin Cancer Res; 2018 Feb 23; 37(1):37. PubMed ID: 29475441 [Abstract] [Full Text] [Related]
39. The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines. Stratford EW, Daffinrud J, Munthe E, Castro R, Waaler J, Krauss S, Myklebost O. Cancer Med; 2014 Feb 23; 3(1):36-46. PubMed ID: 24403055 [Abstract] [Full Text] [Related]
40. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Jang GB, Kim JY, Cho SD, Park KS, Jung JY, Lee HY, Hong IS, Nam JS. Sci Rep; 2015 Jul 23; 5():12465. PubMed ID: 26202299 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]